Seungtaek Kim to Inhibitory Concentration 50
This is a "connection" page, showing publications Seungtaek Kim has written about Inhibitory Concentration 50.
Connection Strength
0.212
-
Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells. J Med Virol. 2021 03; 93(3):1403-1408.
Score: 0.168
-
Design, synthesis and biological evaluation of 2-aminoquinazolin-4(3H)-one derivatives as potential SARS-CoV-2 and MERS-CoV treatments. Bioorg Med Chem Lett. 2021 05 01; 39:127885.
Score: 0.044